Search by Drug Name
A B C D E F G H I J K L M N O P Q R S T U V W X Y ZClinical Trials for RANEXA
- Effects of Ranolazine on Coronary Microvascular Dysfunction in Patients With Hypertrophic Cardiomyopathy
- Targeting Right Ventricle in Pulmonary Hypertension Gilead
- Ranolazine a Potential New Therapeutic Application
- Ranolazine Mediated PVC Reduction in Ischemic Heart Disease
- Ranolazine Among Unrevascularized Chronic Stable Angina Patients
- Impact of Ranolazine in Blood Markers in Women With Angina and Metabolic Syndrome
- Study of Ranolazine in Myotonia Congenita, Paramyotonia Congenita and Myotonic Dystrophy Type 1
- Ranolazine for Diabetic Peripheral Neuropathic Pain (DPNP)
- Effectiveness of Ranolazine on Reducing Chest Pain in Patients With Blockage But no Stents
- Microvascular Assessment of Ranolazine in Non-Obstructive Atherosclerosis (MARINA)
- A Pilot Trial of Ranolazine to Treat Patients With Dilated Cardiomyopathy
- Study of Ranolazine in the Treatment of Pulmonary Hypertension Associated With Diastolic Left Ventricular Dysfunction
- Ranolazine and Microvascular Angina by PET in the Emergency Department
- Study to Reduce Symptoms of Premature Beats With Ranolazine
- A Pilot Study to Enhance F18 FDG-PET Imaging of Prostate Cancers With the Metabolic Inhibitor Ranolazine
- Effect of Ranolazine on Valvular Disease in Patients With Pacemakers
- Targeting the Right Ventricle in Pulmonary Hypertension
- Impact of Ranolazine on Coronary Microcirculatory Resistance
- Pathophysiology and Prevention of Perioperative Myocardial Injury: A Prospective Randomized Controlled Trial
- Impact of Ranolazine on Myocardial Ischemia Detected by High-Field 3T Cardiovascular Magnetic Resonance (CMR) Imaging and P-31 Spectroscopy
- Reduction of Ischemic Myocardium With Ranolazine-Treatment in Patients With Acute Myocardial Ischemia
- Ranolazine Cardioprotection in PCI
- Effects of Ranolazine on Coronary Flow Reserve in Symptomatic Diabetic Patients and CAD
- Long Term Prophylactic Therapy of Congenital Long QT Syndrome Type III (LQT3) With Ranolazine
- Ranolazine for the Treatment of Chest Pain in HCM Patients
- The Effects of Ranolazine on CPET Parameters in Ischemic Cardiomyopathy Patients (ERIC)
- A Phase 1 Study to Assess the Effect of Severe Renal Impairment on the Pharmacokinetics, as Well as Safety/Tolerability, of Ranolazine
- Safety of Amiodarone and Ranolazine Together in Patients With Angina
- Single Cohort 4-period Study to Assess Pharmacokinetics of Metformin Alone and in Combination With Ranolazine
- Single Cohort, 2-Period Study to Assess Pharmacokinetics of Metformin Alone and in Combination With Ranolazine 500 mg
- The Effects of Ranolazine on Exercise Capacity in Patients With Heart Failure With Preserved Ejection Fraction
- Ranolazine for Incomplete Vessel Revascularization Post-Percutaneous Coronary Intervention (PCI)
- Pharmacokinetics of Single-Dose Oral Ranolazine in Hemodialysis Patients
- Ranolazine for the Prevention of Atrial Fibrillation After Electrical Cardioversion
- Ranolazine in Ischemic Cardiomyopathy
- Treatment With Ranolazine in Microvascular Coronary Dysfunction (MCD): Impact on Angina Myocardial Ischemia
- A Study on the Effects of Ranolazine on Exercise Duration in Subjects With Chronic Stable Angina and Coronary Artery Disease (CAD) With Type 2 Diabetes Mellitus (T2DM)
- Ranolazine, Ethnicity and the Metabolic Syndrome
- Ranolazine Implantable Cardioverter-Defibrillator Trial
- Ranolazine and Pulmonary Hypertension
- Ranolazine in Diastolic Heart Failure
- Supervised Treadmill Exercise and Ranolazine for Intermittent Claudication of Lower Extremities
- Study of Ranexa in Patients With Coronary Artery Disease and Painful Polyneuropathy
- Effect of Ranolazine on Echocardiographic Indices of Diastolic Dysfunction
- Microvascular Coronary Disease In Women: Impact Of Ranolazine
- Metabolic Efficiency With Ranolazine for Less Ischemia in Non-ST Elevation Acute Coronary Syndromes
Clinical trials list
click for details